Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
9.38
+0.24 (2.68%)
Jul 3, 2025, 4:00 PM - Market closed
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
$139,254
Profits / Employee
$4,904,159
Market Cap
7.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ADXN News
- 4 days ago - Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs - GlobeNewsWire
- 4 days ago - Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders - GlobeNewsWire
- 9 days ago - Addex Shareholders Approve All Resolutions at Annual General Meeting - GlobeNewsWire
- 15 days ago - Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 16 days ago - Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewsWire
- 4 weeks ago - Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models - GlobeNewsWire
- 4 weeks ago - Addex Convenes Annual General Meeting 2025 - GlobeNewsWire
- 7 weeks ago - Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies - GlobeNewsWire